Harmony Biosciences Holdings Cash Flow Statement 2019-2025 | HRMY

Fifteen years of historical annual cash flow statements for Harmony Biosciences Holdings (HRMY).

Annual Data | Millions of US $ except per share data

Metric Name
Net Income/Loss
Total Depreciation And Amortization - Cash Flow
Other Non-Cash Items
Total Non-Cash Items
Change In Accounts Receivable
Change In Inventories
Change In Accounts Payable
Change In Assets/Liabilities
Total Change In Assets/Liabilities
Cash Flow From Operating Activities
Net Change In Property, Plant, And Equipment
Net Change In Intangible Assets
Net Acquisitions/Divestitures
Net Change In Short-term Investments
Net Change In Long-Term Investments
Net Change In Investments - Total
Investing Activities - Other
Cash Flow From Investing Activities
Net Long-Term Debt
Net Current Debt
Debt Issuance/Retirement Net - Total
Net Common Equity Issued/Repurchased
Net Total Equity Issued/Repurchased
Total Common And Preferred Stock Dividends Paid
Financial Activities - Other
Cash Flow From Financial Activities
Net Cash Flow
Stock-Based Compensation
Common Stock Dividends Paid
202420232022202120202019
$145$129$181$34.60$-36.94$-151.98
$22.55$23.92$24.62$21.08$12.65$3.80
$59.10$31.58$-57.51$42.25$32.94$64.45
$81.65$55.50$-32.90$63.33$45.59$68.25
$-8.89$-19.40$-19.90$-12.67$-17.92$-4.26
$-1.84$-1.07$0.14$-0.61$-2.74$-1.09
$-5.38$8.95$2.79$-1.56$-3.80$4.90
$8.79$46.55$12.87$-1.80$-5.62$0.97
$-7.32$35.04$-4.11$0.63$-11.63$8.29
$220$219$144$98.56$-2.99$-75.44
$-1.15$-0.31$-0.17$-0.30$0.00$-0.15
$0$0$0$-100.00$-2.00$-127.00
$-33.07$-36.97$0$0$0$0
$0$0$0$0$0$0
$-6.76$-9.16$-101.66$0$0$0
$-6.76$-9.16$-101.66$0$0$0
$-26.50$0$-40.00$0$0$0
$-67.48$-46.44$-141.83$-100.30$-2.00$-127.15
$-15.00$-1.25$-2.00$-0.50$97.46$100.00
$0$0$0$0$0$0
$-15.00$-1.25$-2.00$-0.50$97.46$100.00
$6.50$-94.95$8.84$39.37$148$0.09
$6.50$-94.95$8.84$39.37$148$50.09
$0$0$0$0$0$0
$-2.50$-9.36$0$-31.45$-36.06$-6.32
$-11.00$-105.55$6.84$7.42$209$144
$141$67.40$9.48$5.68$204$-58.82
$42.60$31.71$26.17$15.66$4.69$9.91
$0$0$0$0$0$0